Gluskin Sheff & Assoc Inc Gilead Sciences, Inc. Transaction History

Gluskin Sheff & Assoc Inc

$814 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $490,835 - $556,619	-6,699 Reduced 23.4%	21,935 $1.78 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $299,678 - $326,955	-4,053 Reduced 12.4%	28,634 $2.15 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $408,705 - $466,185	-5,377 Reduced 14.13%	32,687 $2.52 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $2.56 Million - $2.92 Million	-33,103 Reduced 46.51%	38,064 $3.16 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $94,352 - $135,457	1,514 Added 2.17%	71,167 $6.11 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $40,665 - $46,450	-683 Reduced 0.97%	69,653 $4.3 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $42,712 - $48,107	-740 Reduced 1.04%	70,336 $4.35 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $547,228 - $685,735	9,448 Added 15.33%	71,076 $4.23 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $336,402 - $381,823	5,185 Added 9.19%	61,628 $4.48 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $5,956 - $6,426	88 Added 0.16%	56,443 $3.94 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $105,360 - $115,120	1,660 Added 3.04%	56,355 $3.88 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $518,880 - $592,042	8,648 Added 18.78%	54,695 $3.54 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $29,401 - $33,501	-519 Reduced 1.11%	46,047 $2.68 Million
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $30,615 - $38,493	-493 Reduced 1.05%	46,566 $2.94 Million
Q2 2020 Aug 11, 2020	SELL	$72.34 - $84.0 $221,360 - $257,040	-3,060 Reduced 6.11%	47,059 $3.62 Million
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $2.66 Million - $3.41 Million	-42,467 Reduced 45.87%	50,119 $3.75 Million
Q4 2019 Feb 12, 2020	SELL	$61.62 - $67.78 $40,237 - $44,260	-653 Reduced 0.7%	92,586 $5.89 Million
Q3 2019 Nov 08, 2019	SELL	$62.51 - $69.0 $10.1 Million - $11.1 Million	-161,006 Reduced 63.33%	93,239 $5.91 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $37,616 - $42,183	-608 Reduced 0.24%	254,245 $17.2 Million
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $4.96 Million - $5.56 Million	79,353 Added 45.22%	254,853 $16.6 Million
Q4 2018 Feb 12, 2019	BUY	$60.54 - $79.0 $10.6 Million - $13.9 Million	175,500 New	175,500 $11 Million

Others Institutions Holding GILD

# of Institutions

1,942

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.12 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.75 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.6 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gluskin Sheff & Assoc Inc, based on Form 13F filings with the SEC.

News

Stay updated on Gluskin Sheff & Assoc Inc with notifications on news.

Account